Tianyin Pharmaceutical Co., Inc. (TPI)

[mlkrborn]

TPI Reports First Quarter Fiscal Year 2012 Financial Results
PR NewswirePress Release: Tianyin Pharmaceutical Co., Inc. – 10 hours ago


* Tianyin Pharmaceutical Co., Inc.

RELATED QUOTES
Symbol Price Change
TPI 1.02 -0.17

CHENGDU, China , Nov. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter of Fiscal Year 2012.

First quarter fiscal year 2012 ending September 30 , 2011 financial highlights

* 1Q FY2012 revenue decreased 20.5% year over year to $17.5 million from $22.0 million in 1Q FY2011,
* 1Q FY2012 operating income delivered $2.2 million , decreasing 52.2% from $ 4.6 million in 1Q FY2011,
* Net Income decreased 55.9% to $1.5 million from $3.4 million in 1Q FY2011,
* Earnings per share of $0.05 per basic share, or $0.05 per diluted share, compared with $0.12 per basic share, or $0.11 per diluted share in 1Q FY2011,
* Cash and cash equivalents totaled $33.3 million on September 30, 2011 ,
* Operating cash flow of 1Q FY2012 improves to $3.6 million , 140% gain from 1Q FY2011.